Omnigen Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.24M
- Investors
-
4
Omnigen General Information
Description
Developer of integrated health and genetic data platforms designed to advance disease research and improve patient care. The company platform offers a secure environment combining electronic health records, genomic information, privacy frameworks, ethical governance, clinical trial referral capabilities, and long-term population registries, enabling healthcare providers, research institutions, and pharmaceutical companies to access diverse datasets while supporting innovation, equitable participation, and the discovery of new treatments that enhance healthcare outcomes across global communities.
Contact Information
Website
www.omnigenbiodata.co.ukCorporate Office
- 11 Hope Street Yard
- Hope Street
- Cambridge CB1 3NA
- England, United Kingdom
Corporate Office
- 11 Hope Street Yard
- Hope Street
- Cambridge CB1 3NA
- England, United Kingdom
Omnigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 21-Sep-2023 | $2.24M | Completed | Generating Revenue | ||
| 2. Seed Round | 20-Apr-2021 | Completed | Startup | |||
| 1. University Spin-Out | 16-Jan-2017 | Completed | Startup |
Omnigen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Omnigen Signals
Omnigen Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Regeneron Pharmaceuticals | Corporation | Minority | ||
| Shackleton Ventures | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| University of Cambridge | University |
Omnigen FAQs
-
When was Omnigen founded?
Omnigen was founded in 2017.
-
Where is Omnigen headquartered?
Omnigen is headquartered in Cambridge, United Kingdom.
-
What is the size of Omnigen?
Omnigen has 16 total employees.
-
What industry is Omnigen in?
Omnigen’s primary industry is Enterprise Systems (Healthcare).
-
Is Omnigen a private or public company?
Omnigen is a Private company.
-
What is the current valuation of Omnigen?
The current valuation of Omnigen is .
-
What is Omnigen’s current revenue?
The current revenue for Omnigen is .
-
How much funding has Omnigen raised over time?
Omnigen has raised $2.75M.
-
Who are Omnigen’s investors?
Regeneron Pharmaceuticals, Shackleton Ventures, Deerfield Management, and University of Cambridge have invested in Omnigen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process